Management of Prenatal Expanded Genetic Carrier Screening Results for Autosomal Recessive Sensorineural Hearing Loss
Otolaryngology–Head and Neck Surgery · 2025
DOI: 10.1002/ohn.1028 ↗At a glance
Journal article in Otolaryngology–Head and Neck Surgery, 2025. Written by Tarika Srinivasan and 3 co-authors. Institution: Harvard Medical School, Boston, Massachusetts, USA. Major MEDLINE topics: Hearing Loss, Sensorineural, Genetic Carrier Screening, Prenatal Diagnosis, Genetic Testing. 48 references.
Abstract (original language)
Objective
Expanded carrier screening (ECS) identified couples at‐risk to have a baby with an autosomal recessive genetic condition. Several genes implicated in sensorineural hearing loss (SNHL) are included in prenatal or preconception genetics ECS testing. Early identification of SNHL risk may enable prognostication of hearing loss, early educational intervention, and minimization of unnecessary diagnostic testing. We sought to describe cases where ECS enabled early SNHL‐risk identification. Study Design Retrospective chart review.
Setting
Maternal‐Fetal Care Center and Otolaryngology department at an academic tertiary hospital.
Methods
Medical records of parent‐infant dyads with positive ECS results for variants in autosomal recessive SNHL genes were reviewed. Data regarding genetic diagnostic testing, newborn hearing screening, time to HL diagnosis, audiological evaluation, and clinical consultations were compiled.
Results
Fifteen pregnant with positive ECS results for SNHL were referred for consultation with a pediatric otolaryngologist and genetic counselor. Generally, these couples were highly educated and adequately insured. 14 had pathogenic variants for GJB2 and 1 for USH2A. Four couples pursued prenatal genetic diagnosis via amniocentesis; 11 couples deferred genetic testing to the postnatal period or waited for initial hearing evaluation. Six babies inherited biallelic GJB2 mutations. Four were found to have SNHL on ABR by age 5 weeks and received follow‐up management, 1 had a normal hearing evaluation despite being gene‐positive, and 1 was lost to follow‐up before hearing evaluation.
Conclusions
Carrier screening and confirmatory prenatal or neonatal genetic testing provided considerable lead time for early audiometric testing and appropriate intervention services including hearing aid fitting.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Harvard Medical School, Boston, Massachusetts, USA.
- Department of Otolaryngology and Communication Enhancement, Boston Children's Hospital, Boston, Massachusetts, USA.
- Maternal Fetal Care Center, Boston Children's Hospital, Boston, Massachusetts, USA.
- Department of Otolaryngology-Head and Neck Surgery, Harvard Medical School, Boston, Massachusetts, USA.
ORCID profiles: Tarika Srinivasan
Cite
APA
Srinivasan, T., Redfield, S., Poorvu, T., & Kenna, M. A. (2025). Management of Prenatal Expanded Genetic Carrier Screening Results for Autosomal Recessive Sensorineural Hearing Loss. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.1028
Vancouver
Srinivasan T, Redfield S, Poorvu T, Kenna MA. Management of Prenatal Expanded Genetic Carrier Screening Results for Autosomal Recessive Sensorineural Hearing Loss. Otolaryngology–Head and Neck Surgery. 2025. doi:10.1002/ohn.1028
BibTeX
@article{Srinivasan2025,
author = {Srinivasan, Tarika and Redfield, Shelby and Poorvu, Tabitha and Kenna, Margaret A},
title = {Management of Prenatal Expanded Genetic Carrier Screening Results for Autosomal Recessive Sensorineural Hearing Loss},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2025},
doi = {10.1002/ohn.1028}
}
EUVIMED